ZBNA
PTCT icon

Zions Bancorporation, National Association’s PTC Therapeutics PTCT Stock Holding History

Zions Bancorporation, National Association’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3K Buy
16
+10
+167% +$722 ﹤0.01% 1382
2026
Q1 		$409 Buy
+6
New +$425 ﹤0.01% 1474

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Zions Bancorporation, National Association's PTCT Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its PTC Therapeutics (PTCT) stake by 167% in Q2 2026, buying an estimated $722 and bringing the position to 16 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1382.

Zions Bancorporation, National Association first reported a position in PTCT in Q1 2026 and has held it in 2 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Zions Bancorporation, National Association held 16 shares of PTC Therapeutics worth $1.3K as of Q2 2026.
  • Zions Bancorporation, National Association bought 10 PTC Therapeutics shares in Q2 2026, an estimated $722.
  • PTC Therapeutics made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1382 holding.
  • Zions Bancorporation, National Association first reported a position in PTC Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.